BioWorld

Nov. 17, 2008

View Archived Issues

Resisting Bug Resistance With New and Better Antibiotics

The emergence of antibiotic resistance has put pressure on scientists working to replace the increasingly ineffective therapies, while a potential epidemic threat moves to the forefront of their minds. Read More

Money Raised Year to Date

Read More

Stock Winners and Losers For The Week

Read More

Phase I Clinical Trials Update: October 2008

Read More

Phase II Clinical Trials Update: October 2008

Read More

Pivotal/Phase III Clinical Trials Update: October 2008

Read More

American College of Rheumatology Annual Meeting

Read More

Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and Infectious Diseases Society of America

Read More

Non-U.S. Clinical Trials And Regulatory Actions: October 2008

Read More

FDA Submissions, Approvals And Other Actions: October 2008

Read More

BioWorld Stock Report For Public Biotechnology Companies

Read More